| Literature DB >> 35564646 |
Shuting Huang1, Fei Huang1, Xiaojun Yang2, Rongbo Xiao1, Yunze Wang3, Meili Xu1, Yuxuan Huang1, Hangyuan Shi1, Peng Wang1.
Abstract
Three soil samples from a chromium (Cr)-contaminated field were classified into five particle fractions (i.e., 0-50 μm, 50-100 μm, 100-250 μm, 250-500 μm, and 500-1000 μm) and were further characterized to study their physicochemical properties and Cr bioaccessibility. The results indicated that the gastrointestinal bioaccessibility estimated by the Solubility Bioaccessibility Research Consortium (SBRC) method was on average 15.9% higher than that by the physiologically based extraction test (PBET) method. The health risk of all samples was within the safe range, and the health risk based on total Cr content may be overestimated by an average of 13.2 times compared to the bioaccessibility-based health risk. The health risk investigated from metal content was mainly contributed by the 50-250 μm fraction, which was 47.5, 50.2, and 43.5% for low-, medium-, and high-level polluted soils, respectively. As for the combined effect, the fractions of 100-250 μm and 500-1000 μm contributed the highest proportion to health risk, which was 57.1, 62.1, and 64.4% for low-level, medium-level, and high-level polluted soils, respectively. These results may further deepen the understanding of health risk assessment and quantify the contribution of the soil particle mass to health risk.Entities:
Keywords: Cr; bioaccessibility; contribution; particle mass; particle size; risk assessment
Mesh:
Substances:
Year: 2022 PMID: 35564646 PMCID: PMC9100977 DOI: 10.3390/ijerph19095253
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Physicochemical properties of various particle size fractions.
| Soil Properties | Particle Fraction (μm) | ||||
|---|---|---|---|---|---|
| 0–50 | 50–100 | 100–250 | 250–500 | 500–1000 | |
| Low | |||||
| pH | 4.95 ± 0.06 a | 5.09 ± 0.26 a | 5.16 ± 0.03 a | 5.21 ± 0.05 a | 5.65 ± 0.57 a |
| OM (mg·kg−1) | 508.68 ± 34.56 ab | 570.85 ± 42.83 a | 504.53 ± 71.45 ab | 545.44 ± 65.59 ab | 463.44 ± 46.8 b |
| CEC (cmol+·kg−1) | 1.65 ± 0.27 a | 1.29 ± 0.13 b | 1.14 ± 0.02 b | 1.38 ± 0.07 ab | 1.21 ± 0.04 b |
| Total Fe (mg·kg−1) | 4540.58 ± 284.49 a | 4691.3 ± 299.08 a | 3146.38 ± 172.68 b | 2317.39 ± 492.75 c | 2015.94 ± 65.27 c |
| Medium | |||||
| pH | 8.35 ± 0.09 a | 7.71 ± 0.11 a | 7.86 ± 0.45 a | 7.71 ± 0.51 a | 7.94 ± 0.39 a |
| OM (mg·kg−1) | 649.15 ± 24.42 ab | 677.18 ± 49.86 a | 597.34 ± 27.31 bc | 613.38 ± 24.66 bc | 585.27 ± 19.57 c |
| CEC (cmol+·kg−1) | 3.41 ± 0.13 a | 2.14 ± 0.25 b | 0.83 ± 0.16 c | 0.28 ± 0.06 d | 0.14 ± 0.01 d |
| Total Fe (mg·kg−1) | 45028.99 ± 652.66 a | 37537.97 ± 1383.63 b | 21666.67 ± 3263.28 d | 22616.23 ± 2826.12 d | 30348.41 ± 4589.14 c |
| High | |||||
| pH | 9.5 ± 0.04 a | 9.37 ± 0.18 a | 9.67 ± 0.06 a | 9.46 ± 0.12 a | 9.63 ± 0.27 a |
| OM (mg·kg−1) | 741.33 ± 15.03 a | 760.8 ± 10.74 a | 680.06 ± 16.44 b | 658.8 ± 8.99 b | 601.49 ± 19.79 c |
| CEC (cmol+·kg−1) | 9.66 ± 0.13 b | 9.71 ± 0.18 b | 10.45 ± 0.12 a | 9.83 ± 0.03 b | 8.23 ± 0.29 c |
| Total Fe (mg·kg−1) | 2254.48 ± 236.38 a | 2102.61 ± 286.65 a | 2152.06 ± 327.93 a | 1818.92 ± 40.96 a | 1827.54 ± 65.27 a |
All values are presented as mean ± standard deviation. Means with different letters in the same row are significantly different at p < 0.05; OM: organic matter; CEC: cation exchange capacity.
Figure 1Particle mass distribution of all samples (a). Total Cr content of all samples (b). Accumulation factor of Cr of all samples (c). The error bars represent standard deviation. Means with different letters in the same row are significantly different at p < 0.05.
Bioaccessible Cr concentrations in the simulated gastrointestinal solutions based on the physiologically based extraction test (PBET) and Solubility Bioaccessibility Research Consortium (SBRC) methods for the three samples.
| Element (mg·kg−1) | Particle Fraction (μm) | ||||
|---|---|---|---|---|---|
| 0–50 | 50–100 | 100–250 | 250–500 | 500–1000 | |
| Low | |||||
| PBET-G | 19.78 ± 2.51 c | 43.23 ± 2.97 b | 59.43 ± 1.58 a | 40.1 ± 1.46 b | 38.04 ± 1.45 b |
| PBET-GI | 27.27 ± 0.45 c | 91.46 ± 1.94 a | 90.55 ± 0.71 a | 85.91 ± 1.94 ab | 81.83 ± 3.83 b |
| SBRC-G | 25.92 ± 0.32 d | 87.93 ± 1.75 a | 75.19 ± 0.85 b | 68.7 ± 1.65 c | 66.36 ± 1.64 c |
| SBRC-GI | 38.19 ± 3.98 c | 68.76 ± 2.57 a | 54.5 ± 7.44 b | 26.53 ± 1.05 d | 34.05 ± 2.43 cd |
| Medium | |||||
| PBET-G | 25.23 ± 1.3 b | 50.66 ± 1.52 a | 46.39 ± 1.5 a | 44.73 ± 5.08 a | 42.4 ± 4.72 a |
| PBET-GI | 14.99 ± 0.46 c | 114.62 ± 7.61 a | 91.45 ± 1.96 b | 82.07 ± 0.35 b | 73.12 ± 0.93 b |
| SBRC-G | 49.54 ± 1.3 d | 116.41 ± 1.41 a | 95.41 ± 1.78 b | 87.93 ± 1.75 bc | 81.84 ± 6.87 c |
| SBRC-GI | 35.44 ± 0.98 c | 89.29 ± 5.4 a | 68.76 ± 2.57 b | 59.78 ± 5.03 b | 42.39 ± 4.8 c |
| High | |||||
| PBET-G | 1669.38 ± 30.11 b | 2112.26 ± 19.46 a | 1204.97 ± 68.28 c | 1098.97 ± 53.74 c | 880.58 ± 12.02 d |
| PBET-GI | 1410.81 ± 1.91 b | 1907.94 ± 15.62 a | 1203.99 ± 32.07 c | 1018.39 ± 10.02 d | 1068.91 ± 25.73 d |
| SBRC-G | 6340.63 ± 96.01 b | 9380.3 ± 139.9 a | 6525.62 ± 27.58 b | 5861.86 ± 12.02 c | 5411.21 ± 275.79 d |
| SBRC-GI | 2573.38 ± 45.05 bc | 3752.62 ± 43.5 a | 2714.97 ± 145.17 b | 2428.25 ± 90.11 bc | 2389.31 ± 185.22 c |
All values are presented as mean ± standard deviation. Means with different letters in the same row are significantly different at p < 0.05. “G”, gastric phase; “GI”, gastrointestinal phase.
Figure 2Cr bioaccessibility of different fractions estimated through the PBET and SBRC methods. All values are presented as mean ± standard deviation. The error bars represent standard deviation. Means with different letters in the same row are significantly different at p < 0.05.
Figure 3Cr hazard quotient and the particle mass contribution of Cr hazard quotient of children over different particle size fractions. HQ: hazard quotient; TC: total Cr content; SBRC: Cr bioaccessible concentration estimated through the SBRC method; PBET: Cr bioaccessible concentration estimated through the PBET method; I: Scenario I; II: Scenario II; A: 0–50 μm; B: 50–100 μm; C: 100–250 μm; D: 250–500 μm; E: 500–1000 μm; F: 0–50 μm; G: 0–100 μm; H: 0–250 μm; I: 0–500 μm; and J: 0–1000 μm.
Figure 4Contribution of different particle size fractions to Cr hazard quotient. Health risk based on (a) metal content and (b) combined effect of metal content and particle mass. TC: total Cr content; SBRC: Cr bioaccessible concentration estimated through the SBRC method; PBET: Cr bioaccessible concentration estimated through the PBET method.